-
Vodafone Idea Share Price Up 1.25% Ahead of Q1FY27 Earnings
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Vodafone Idea share price up 1.25% to Rs 12.91 on 10 Aug 2026 ahead of Q1FY27 earnings. MCap Rs 1,39,870 Cr. 52W high Rs 15.35; low Rs 6.12. 110.95% above 52-week low.
-
Garuda Construction Share Price Jumps 11% on Q1 PAT Up 48%
- August 10, 2026
- Posted by: Kunal Singla
- Category: News
Garuda Construction share price jumps 11% on 10 Aug 2026 after Q1FY27 net profit rose 48% to Rs 41.5 crore in the June quarter. Construction and engineering company surges.
-
COLAB Technologies Q1 FY27 Results: Revenue Rs 22 Cr, PAT Rs 1.00 Cr and Key Highlights
- August 10, 2026
- Posted by: Lakshit Sharma
- Category: News
COLAB Technologies Q1 FY27 results: Revenue Rs 22 Cr (+3.39% YoY), PAT Rs 1.00 Cr (+12.19% YoY). Key highlights, financial analysis and FY27 outlook.
-
Zee Entertainment Share Price: SAT Petition Against SEBI Bar
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Zee Entertainment share price in focus as ZEEL and Punit Goenka move SAT against SEBI’s July 31 market-access bar. ZEEL barred 2 months, Goenka 12 months.
-
Aarti Industries Share: Pros and Cons Every Investor Must Know in 2026
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Aarti Industries share pros and cons: India’s largest benzene specialty chemical company at 34x PE during transition-year ROE depression analysed for 2026.
-
Clean Science and Technology Share: Pros and Cons Every Investor Must Know in 2026
- August 10, 2026
- Posted by: Kunal Singla
- Category: News
Clean Science and Technology share pros and cons: green chemistry specialty leader at 35.22x PE with MEHQ and BHA global leadership analysed for 2026.
-
Sharda Cropchem Share: Pros and Cons Every Investor Must Know in 2026
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Sharda Cropchem share pros and cons: India’s cheapest quality company at 11.86x PE with 21.71% ROE and agrochemical registration moat analysed for 2026.
-
Laurus Labs Share: Pros and Cons Every Investor Must Know in 2026
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Laurus Labs share pros and cons: pharma ARV API leader transitioning to CDMO at very expensive 91x PE analysed for 2026.
-
Sumitomo Chemical India Share: Pros and Cons Every Investor Must Know in 2026
- August 10, 2026
- Posted by: Kunal Singla
- Category: News
Sumitomo Chemical India share pros and cons: Japan MNC agrochemical subsidiary at premium 45x PE with proprietary molecule access analysed for 2026.